| Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders GS Malhi, D Bassett, P Boyce, R Bryant, PB Fitzgerald, K Fritz, ... Australian & New Zealand Journal of Psychiatry 49 (12), 1087-1206, 2015 | 977 | 2015 |
| The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders GS Malhi, E Bell, D Bassett, P Boyce, R Bryant, P Hazell, M Hopwood, ... Australian & New Zealand Journal of Psychiatry 55 (1), 7-117, 2021 | 470 | 2021 |
| Staging in bipolar disorder: from theoretical framework to clinical utility M Berk, R Post, A Ratheesh, E Gliddon, A Singh, E Vieta, AF Carvalho, ... World Psychiatry 16 (3), 236-244, 2017 | 228 | 2017 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin … CA Bousman, JM Stevenson, LB Ramsey, K Sangkuhl, JK Hicks, ... Clinical Pharmacology & Therapeutics 114 (1), 51-68, 2023 | 194 | 2023 |
| Improved antidepressant remission in major depression via a pharmacokinetic pathway polygene pharmacogenetic report AB Singh Clinical Psychopharmacology and Neuroscience 13 (2), 150, 2015 | 150 | 2015 |
| The 2020 Royal Australian and New Zealand College of psychiatrists clinical practice guidelines for mood disorders: Bipolar disorder summary GS Malhi, E Bell, P Boyce, D Bassett, M Berk, R Bryant, M Gitlin, ... Bipolar disorders 22 (8), 805-821, 2020 | 134 | 2020 |
| The limitations of using randomised controlled trials as a basis for developing treatment guidelines R Mulder, AB Singh, A Hamilton, P Das, T Outhred, G Morris, D Bassett, ... BMJ Ment Health 21 (1), 4-6, 2018 | 118 | 2018 |
| The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: major depression summary GS Malhi, E Bell, AB Singh, D Bassett, M Berk, P Boyce, R Bryant, M Gitlin, ... Bipolar disorders 22 (8), 788-804, 2020 | 117 | 2020 |
| Adjunctive minocycline treatment for major depressive disorder: a proof of concept trial OM Dean, B Kanchanatawan, M Ashton, M Mohebbi, CH Ng, M Maes, ... Australian & New Zealand Journal of Psychiatry 51 (8), 829-840, 2017 | 112 | 2017 |
| ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression AB Singh, CA Bousman, CH Ng, K Byron, M Berk Translational psychiatry 2 (11), e198-e198, 2012 | 109 | 2012 |
| Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: major depression summary GS Malhi, T Outhred, A Hamilton, PM Boyce, R Bryant, PB Fitzgerald, ... Medical Journal of Australia 208 (4), 175-180, 2018 | 98 | 2018 |
| Cognitive side-effects of electroconvulsive therapy: what are they, how to monitor them and what to tell patients RJ Porter, BT Baune, G Morris, A Hamilton, D Bassett, P Boyce, ... BJPsych open 6 (3), e40, 2020 | 92 | 2020 |
| A brief review of exercise, bipolar disorder, and mechanistic pathways D Thomson, A Turner, S Lauder, ME Gigler, L Berk, AB Singh, JA Pasco, ... Frontiers in psychology 6, 147, 2015 | 85 | 2015 |
| A consensus statement for safety monitoring guidelines of treatments for major depressive disorder S Dodd, GS Malhi, J Tiller, I Schweitzer, I Hickie, JP Khoo, DL Bassett, ... Australian & New Zealand Journal of Psychiatry 45 (9), 712-725, 2011 | 83 | 2011 |
| A pragmatic randomized controlled trial exploring the relationship between pulse number and response to repetitive transcranial magnetic stimulation treatment in depression PB Fitzgerald, KE Hoy, J Reynolds, A Singh, R Gunewardene, C Slack, ... Brain stimulation 13 (1), 145-152, 2020 | 62 | 2020 |
| Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: bipolar disorder summary GS Malhi, T Outhred, G Morris, PM Boyce, R Bryant, PB Fitzgerald, ... Medical Journal of Australia 208 (5), 219-225, 2018 | 61 | 2018 |
| Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression C Ng, J Sarris, A Singh, C Bousman, K Byron, LH Peh, DJ Smith, CH Tan, ... Human Psychopharmacology: Clinical and Experimental 28 (5), 516-522, 2013 | 59 | 2013 |
| Antidepressant pharmacogenetics AB Singh, CA Bousman, C Ng, M Berk Current opinion in psychiatry 27 (1), 43-51, 2014 | 57 | 2014 |
| Defining melancholia: a core mood disorder G Parker, D Bassett, T Outhred, G Morris, A Hamilton, P Das, BT Baune, ... Bipolar disorders 19 (3), 235-237, 2017 | 55 | 2017 |
| Stimulants for depression: On the up and up? GS Malhi, Y Byrow, D Bassett, P Boyce, M Hopwood, W Lyndon, R Mulder, ... Australian & New Zealand Journal of Psychiatry 50 (3), 203-207, 2016 | 51 | 2016 |
Gin S. MalhiProfessor of Psychiatry, University of SydneyAdresse e-mail validée de sydney.edu.au